Nazanin mahinparvar | Medicine | Best Researcher Award

Postdoc at Stanford university, United States.

Dr. Nazanin Mahinparvar is a postdoctoral scholar at Stanford University, focusing on bioengineering and pain management. She brings a blend of medical and research expertise to her work, aiming to develop innovative gene therapies that offer non-addictive, effective treatments for chronic pain. Her research in synthetic biology, combined with her clinical background as an emergency medicine physician, underscores her commitment to translating laboratory discoveries into practical healthcare solutions. Throughout her career, she has received numerous accolades for her dedication to patient care and research excellence, including the Best Physician Award during the COVID-19 pandemic. Her approach to research is driven by a patient-centered perspective, making her work both scientifically rigorous and highly relevant to addressing current health challenges. Dr. Mahinparvar’s focus on developing HSV-based biotechnologies has the potential to reshape pain management therapies, positioning her as a significant contributor to advancements in medical science.

Profile👤

Scopus

Education 🎓

Dr. Nazanin Mahinparvar’s educational journey is marked by excellence and a clear dedication to advancing medical knowledge. She began her studies in Biology at SAMPAD in Iran, followed by an MD at Isfahan Medical University, where she was recognized with high honors. Her medical education included an emphasis on pain management, an area she explored further during her mandatory medical service program. Her commitment to lifelong learning and research brought her to Stanford University for a prestigious postdoctoral position in bioengineering. Dr. Mahinparvar’s educational background integrates both foundational medical training and specialized knowledge in synthetic biology and gene therapy. Her academic journey has been marked by a strong interdisciplinary focus, with formal training that spans basic sciences, clinical practice, and cutting-edge bioengineering. This diverse educational foundation provides her with a unique perspective, enabling her to bridge the gap between laboratory research and patient-centered clinical applications.

Experience

Dr. Nazanin Mahinparvar has extensive experience in both clinical and research settings, blending hands-on patient care with innovative scientific research. Her early career as a physician involved managing healthcare in underserved areas, where she was honored with the Best Doctor Award for her exceptional patient care. Following this, she served as an emergency medicine physician, honing her ability to operate under pressure. During her postdoctoral work at Stanford, she focused on developing non-toxic HSV-based therapies for chronic pain and neurological disorders. Her clinical experience in pain management, coupled with her research in gene therapy and synthetic biology, has positioned her as a leader in innovative medical research. Dr. Mahinparvar’s experience is a blend of practical and scientific expertise, which she continually refines through collaboration with top scientists and participation in clinical trials. Her background uniquely equips her to drive impactful advancements in pain management and gene-based therapies.

Research Interests 🔬

Dr. Mahinparvar’s research interests focus on engineering advanced, safe, and efficient gene therapies for chronic pain and neurological disorders. She specializes in developing non-addictive pain management treatments using synthetic biology and gene engineering, with a particular interest in non-toxic HSV-based technologies. Dr. Mahinparvar’s work aims to address global health challenges by providing affordable, accessible solutions for conditions that currently lack effective, low-risk treatments. At Stanford’s Wu Tsai Neurosciences Institute, her research delves into combining gene therapy with bioengineering to create precise, targeted interventions. Her early research on selenium’s effects on respiratory functions in ICU patients sparked her interest in translational medicine, which she has expanded to chronic pain and neuro-oncology applications. Dr. Mahinparvar’s research is ultimately driven by her commitment to improving patient outcomes and advancing the field of pain management through innovative, cross-disciplinary approaches that bridge the laboratory and the clinic.

Awards and Honors 🏆

Conclusion